SAM #75N98026R00136

Sources Sought: Centralized Repository Services for Chemical and Biological Compounds (NIH/NIDA)

This opportunity is a Sources Sought notice from the National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA), seeking small businesses to provide centralized repository services for chemical and biological compounds. - The selected vendor will: - Receive, inventory, analyze, store, and distribute chemical and biological compounds, including controlled substances - Handle compounds prepared under both non-GMP and GMP conditions, in quantities from milligrams to several kilograms - Store approximately 10,000 compounds under various environmental conditions - Perform analytical testing (TLC, HPLC, MS, GC, NMR, Optical Rotation) - Prepare and ship compounds as needed - Maintain secure record keeping and inventory tracking systems - Purchase commercially available compounds as required - The facility must have DEA Research Registration for Schedules II-V and potentially Schedule I controlled substances, in compliance with the Controlled Substances Act of 1970 - The NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences) - No specific OEMs, vendors, or products are named; the focus is on service capability - This is not a solicitation for products, but for specialized repository and analytical services - Responses will inform the government's acquisition strategy

Description

TITLE: Purity Specifications, Storage and Distribution for Medications Development

This is a Sources Sought notice. THIS IS NOT A REQUEST FOR PROPOSALS, ABSTRACTS, OR QUOTATIONS. This notice is for information and planning purposes only and does not commit the Government to any contractual agreement. The Government does not intend to award a contract based on responses under this announcement nor otherwise pay for preparing any information sent for the Government's use. Any proprietary information should be so marked.

PROJECT REQUIREMENTS

The National Institute on Drug Abuse (NIDA) seeks capability statements from small businesses having the in-house capability to act as a centralized repository for compounds (i.e., chemical and biological) from domestic and international investigators, commercial sources, and pharmaceutical companies. Specifically, the project requires the following tasks:

The major goal of this project is to provide NIDA and other NIH Institutes with a holding site which has the capability to inventory, analyze and store compounds, prepared under both non-GMP (Good Manufacturing Practices) and GMP conditions, in amounts ranging from milligram quantities to several kilograms. In accordance with the Controlled Substances Act of 1970, DEA Research Registration for Schedules II to V and potentially Schedule I controlled substances will be required.

Please see the attachment for more details.

View original listing